Do you want to read an article? Please log in or register.
Basiliximab Induction Immunosuppression and Lung Transplant Outcomes: Propensity Analysis in a Multicenter Cohort
Further Publications
RECOMMENDED
Related content
RECOMMENDED
Further Publications
Single Versus Double Lung Transplant in Older Adults: A Propensity-Matched Analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 2
Recommended by
Dr Marcus Hesse, Faculty Member
Chest
Weingarten N, Mehta AC, Budev M, Ahmad U, Yun J, McCurry K, Elgharably H
doi: 10.1016/j.chest.2024.08.044
RECOMMENDED
Further Publications
Extracorporeal membrane oxygenation as a bridge to lung transplantation: 5-year outcomes and bridge to decision in a large, older cohort
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Res
Daar JA, Toyoda Y, Shigemura N, Baskin SM, Desai P, Gordon M
doi: 10.1186/s12931-024-02968-y
RECOMMENDED
Lung Cancer
Long-Term Results of Segmentectomy vs. Lobectomy for c-Stage IA Lung Cancer: A Real-Life Study with a Propensity Score Analysis Based on a National Cohort
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
J Clin Med
Lopez I, Aguinagalde B, Ferrer-Bonsoms JA, Sánchez L, Ascanio F, Sesma J, Recuero JL, Fernandez-Monge A, Lizarbe JA, Embun R
doi: 10.3390/jcm14072267
RECOMMENDED
Lung Cancer
Long term outcomes after lobar versus sublobar resection for patients with Non-Small cell lung Cancer: Systematic review and individual patient data Meta-Analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer
Tasoudis P, Loufopoulos G, Manaki V, Doerr M, Agala CB, Long JM, Haithcock BE
doi: 10.1016/j.lungcan.2024.107929
Pulmonary Fibrosis
Impact of availability of a highly effective Cystic Fibrosis treatment (elexacaftor/tezacaftor/ivacaftor) on lung transplant waitlist and lung transplantation trends in the US
Respir Med
Merlo C, Geiger JM, Wang Z, Lyden GR, Schladt DP, McGarry L
doi: 10.1016/j.rmed.2025.108171
Lung Cancer
Immunotherapy Improves Clinical Outcome in Kirsten Rat Sarcoma Virus-Mutated Patients with Unresectable Non-Small Cell Lung Cancer Stage III: A Subcohort Analysis of the Austrian Radio-Oncological Lung Cancer Study Association Registry (ALLSTAR)
J Clin Med
Ruznic E, Klebermass M, Zellinger B, Langer B, Grambozov B, Purevdorj A, Karner J, Gruber G, Stana M, Minasch D, Kirchhammer K, Steffal C, Stranzl H, Moosbrugger R, Feurstein P, Dieckmann K, Zehentmayr F, ALLSTAR Group
doi: 10.3390/jcm14030945
Lung Cancer
Conversion Surgery for Initially Unresectable Stage Ⅲ Nonsmall Cell Lung Cancer After Induction Treatment of Immunochemotherapy: A Multicenter Study
Clin Lung Cancer
Wang M, Wang X, Yang R, Geng M, Zhang S, Yang Z, Huang Q, Wang S, Xu S, Jiang K, Liao Y
doi: 10.1016/j.cllc.2024.11.005
Lung Cancer
Segmentectomy vs. Lobectomy in stage IA non-small cell lung cancer: A systematic review and meta-analysis of perioperative and survival outcomes
Lung Cancer
Bertolaccini L, Tralongo AC, Del Re M, Facchinetti F, Ferrara R, Franchina T, Graziano P, Malapelle U, Menis J, Passaro A, Pilotto S, Ramella S, Rossi G, Trisolini R, Cinquini M, Passiglia F, Novello S
doi: 10.1016/j.lungcan.2024.107990
Bronchi
PMN-MDSCs Orchestrate the Immunosuppressive Microenvironment in the Lung and Are Associated With Clinical Outcome in Bronchiectasis
Respirology
Duan J, Huang Z, Jiang Y, Xian M, Wang W, Yang Z, Shi X, Jia N, Li N, Li B, Lian Z, Ning X, Guo Y, Tang H, Dong M, He L, Yang W, Mo R, Huang P, Yang G, Chen R, Cheng L, Li J
doi: 10.1111/resp.70045